119 related articles for article (PubMed ID: 10549508)
1. Topotecan as a 21-day continuous infusion with accelerated 3D-conformal radiation therapy for patients with glioblastoma.
Grabenbauer GG; Buchfelder M; Schrell U; Fahlbusch R; Sauer R; Staab HJ
Front Radiat Ther Oncol; 1999; 33():364-8. PubMed ID: 10549508
[No Abstract] [Full Text] [Related]
2. Prolonged infusional topotecan and accelerated hyperfractionated 3d-conformal radiation in patients with newly diagnosed glioblastoma--a phase I study.
Grabenbauer GG; Anders K; Fietkau RJ; Klautke G; Feldmann HJ; Weiser S; Staab HJ; Krauseneck P; Sauer R
J Neurooncol; 2002 Dec; 60(3):269-75. PubMed ID: 12510778
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).
Gross MW; Altscher R; Brandtner M; Häusser-Mischlich H; Kiricuta IC; Siegmann AD; Engenhart-Cabillic R
Strahlenther Onkol; 2001 Dec; 177(12):656-61. PubMed ID: 11789404
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
Varveris H; Petinelli E; Stratakis J; Mazonakis M
Oncol Rep; 2008 Feb; 19(2):447-55. PubMed ID: 18202794
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma.
Lesimple T; Hassel MB; Gédouin D; Seigneuret E; Carsin B; Hamlat A; Riffaud L; Simon H; Malhaire JP; Guégan Y
J Neurooncol; 2003 Nov; 65(2):141-8. PubMed ID: 14686734
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.
Fisher BJ; Scott C; Macdonald DR; Coughlin C; Curran WJ
J Clin Oncol; 2001 Feb; 19(4):1111-7. PubMed ID: 11181676
[TBL] [Abstract][Full Text] [Related]
7. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme.
Klautke G; Schütze M; Bombor I; Benecke R; Piek J; Fietkau R
J Neurooncol; 2006 Apr; 77(2):199-205. PubMed ID: 16314953
[TBL] [Abstract][Full Text] [Related]
10. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
[TBL] [Abstract][Full Text] [Related]
11. Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study.
Lesimple T; Riffaud L; Frappaz D; Ben Hassel M; Gédouin D; Bay JO; Linassier C; Hamlat A; Piot G; Fabbro M; Saïkali S; Carsin B; Guégan Y
J Neurooncol; 2009 Jun; 93(2):253-60. PubMed ID: 19139825
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
Kocher M; Eich HT; Semrau R; Güner SA; Müller RP
Strahlenther Onkol; 2005 Jan; 181(1):20-5. PubMed ID: 15660189
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of topotecan for pediatric central nervous system tumors.
Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.
Frangoul H; Ames MM; Mosher RB; Reid JM; Krailo MD; Seibel NL; Shaw DW; Steinherz PG; Whitlock JA; Holcenberg JS
Clin Cancer Res; 1999 Dec; 5(12):3956-62. PubMed ID: 10632325
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme.
Moyal EC; Laprie A; Delannes M; Poublanc M; Catalaa I; Dalenc F; Berchery D; Sabatier J; Bousquet P; De Porre P; Alaux B; Toulas C
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1396-401. PubMed ID: 17570606
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
[TBL] [Abstract][Full Text] [Related]
18. The use of continuous infusion topotecan in persistent and recurrent ovarian cancer.
Elkas JC; Holschneider CH; Katz B; Li AJ; Louie R; McGonigle KF; Berek JS
Int J Gynecol Cancer; 2003; 13(2):138-41. PubMed ID: 12657113
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.
Stevenson JP; Scher RM; Kosierowski R; Fox SC; Simmonds M; Yao KS; Green F; Broom C; Fields SZ; Krebs JB; O'Dwyer PJ
Eur J Cancer; 1998 Aug; 34(9):1358-62. PubMed ID: 9849417
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]